Terrence Higgins Trust responds to All Wales Medicines Strategy Group PrEP recommendation
Our full reaction to the advice which would deny PrEP to people in Wales.
Sarah Fuhrmann, National Director for Terrence Higgins Trust in Wales, said:
“We are disappointed by this short-sighted recommendation to deny PrEP to people at risk of HIV in Wales. For every person who receives an HIV diagnosis, the Welsh NHS will pay on average £360,000 in lifetime treatment costs. PrEP can save the NHS this money in the long term, whilst taking us one step closer to ending the HIV epidemic.
“This recommendation could mean a wasted opportunity to tackle the HIV epidemic in Wales, where investment in HIV prevention has been patchy at best, and where late HIV diagnosis rates are the highest in all of the UK. This is all the more disappointing so soon after Scotland made history by becoming the first UK country to fund PrEP on the NHS.
“We realise this is not the final decision, but if acted upon, this advice would lead to a postcode lottery within the UK, with major inequalities between borders in terms of who is protected against HIV.”